BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 28669922)

  • 1. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
    Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.
    Kurosawa S; Yamaguchi T; Oshima K; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1851-1858. PubMed ID: 31129353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study.
    Riemens A; Te Boome LC; Kalinina Ayuso V; Kuiper JJ; Imhof SM; Lokhorst HM; Aniki R
    Acta Ophthalmol; 2014 Feb; 92(1):82-7. PubMed ID: 23601505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.
    Pallua S; Giesinger J; Oberguggenberger A; Kemmler G; Nachbaur D; Clausen J; Kopp M; Sperner-Unterweger B; Holzner B
    Bone Marrow Transplant; 2010 Oct; 45(10):1534-9. PubMed ID: 20228854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of the type of hematopoietic stem-cell transplant on quality of life and psychopathology].
    Janicsák H; Masszi T; Reményi P; Ungvari GS; Gazdag G
    Ideggyogy Sz; 2023 Jan; 76(1-2):25-35. PubMed ID: 36892298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coping and Modifiable Psychosocial Factors are Associated with Mood and Quality of Life in Patients with Chronic Graft-versus-Host Disease.
    Jacobs JM; Fishman S; Sommer R; Sereno I; Fenech A; Jankowski AL; Traeger L; Greer JA; Vanderklish J; Hunnewell C; Saylor M; Chen YB; Spitzer T; DeFilipp Z; Temel JS; El-Jawahri A
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2234-2242. PubMed ID: 31260800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?
    Perić Z; Desnica L; Duraković N; Ostojić A; Pulanić D; Serventi-Seiwerth R; Prenc E; Basak G; Vrhovac R; Pavletic SZ; Nemet D
    Croat Med J; 2016 Feb; 57(1):6-15. PubMed ID: 26935610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.
    Pidala J; Kurland B; Chai X; Majhail N; Weisdorf DJ; Pavletic S; Cutler C; Jacobsohn D; Palmer J; Arai S; Jagasia M; Lee SJ
    Blood; 2011 Apr; 117(17):4651-7. PubMed ID: 21355084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
    Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
    Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease.
    Patel SS; Hong S; Rybicki L; Farlow S; Dabney J; Kalaycio M; Sobecks R; Majhail NS; Hamilton BK
    Transplant Cell Ther; 2023 Jul; 29(7):465.e1-465.e7. PubMed ID: 37003415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms, Cytokines, and Quality of Life in Patients Diagnosed with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
    Lynch Kelly D; Lyon DE; Ameringer SA; Elswick RK
    Oncol Nurs Forum; 2015 May; 42(3):265-75. PubMed ID: 25901378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life associated with acute and chronic graft-versus-host disease.
    Lee SJ; Kim HT; Ho VT; Cutler C; Alyea EP; Soiffer RJ; Antin JH
    Bone Marrow Transplant; 2006 Aug; 38(4):305-10. PubMed ID: 16819438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan.
    Hayakawa A; Sato I; Kamibeppu K; Ishida Y; Inoue M; Sato A; Shiohara M; Yabe H; Koike K; Adachi S; Atsuta Y; Yamashita T; Kanda Y; Okamoto S
    Int J Hematol; 2022 Jan; 115(1):123-128. PubMed ID: 34601694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Is this the GVHD?" A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service.
    de Vere Hunt I; Kilgour JM; Danby R; Peniket A; Matin RN
    Health Qual Life Outcomes; 2021 Jan; 19(1):11. PubMed ID: 33413414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and recovery after graft-versus-host disease.
    Baker KS; Fraser CJ
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):333-41. PubMed ID: 18503996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5.
    Kurosawa S; Yamaguchi T; Mori A; Tsukagoshi M; Okuda I; Ikeda M; Fuji S; Yamashita T; Ogawa C; Ito A; Tanaka T; Inamoto Y; Kim SW; Fukuda T
    Transplant Cell Ther; 2021 Nov; 27(11):935.e1-935.e9. PubMed ID: 34371214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.
    Sun YC; Chai X; Inamoto Y; Pidala J; Martin PJ; Flowers ME; Shen TT; Lee SJ; Jagasia M
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1687-91. PubMed ID: 26033283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantation.
    Rosenberg AR; Syrjala KL; Martin PJ; Flowers ME; Carpenter PA; Salit RB; Baker KS; Lee SJ
    Cancer; 2015 Dec; 121(23):4250-7. PubMed ID: 26288023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.